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Abstract
Background: The relationship between histological chorioamnionitis and haematological and biochemical markers in
mothers and infants at delivery, and in infants postnatally, is incompletely characterised. These markers are widely used in
the diagnosis of maternal and neonatal infection. Our objective was to investigate the effects of histological
chorioamnionitis (HCA) on haematological and biochemical inflammatory markers in mothers and infants at delivery,
and in infants post-delivery.
Methods: Two hundred and forty seven mothers, delivering 325 infants, were recruited at the only tertiary perinatal centre
in Western Australia. Placentae were assessed for evidence of HCA using a semi-quantitative scoring system. Maternal high
sensitivity C-reactive protein (hsCRP), procalcitonin, and umbilical cord hsCRP, procalcitonin, white cell count and absolute
neutrophil count were measured at delivery. In infants where sepsis was clinically suspected, postnatal CRP, white cell count
and absolute neutrophil count were measured up to 48 hours of age. The effect of HCA on maternal, cord and neonatal
markers was evaluated by multivariable regression analysis.
Results: The median gestational age was 34 weeks and HCA was present in 26 of 247 (10.5%) placentae. Mothers whose
pregnancies were complicated by HCA had higher hsCRP (median 26 (range 2–107) versus 5.6 (0–108) mg/L; P,0.001).
Histological chorioamnionitis was associated with higher umbilical cord hsCRP (75th percentile 2.91 mg/L (range 0–63.9)
versus 75th percentile 0 mg/L (0–45.6); P,0.001) and procalcitonin (median 0.293 (range 0.05–27.37) versus median 0.064
(range 0.01–5.24) ug/L; P,0.001), with a sustained increase in neonatal absolute neutrophil count (median 4.5 (0.1–
26.4)6109/L versus 3.0 (0.1–17.8)6109/L), and CRP up to 48 hours post-partum (median 10 versus 6.5 mg/L) (P,0.05 for
each).
Conclusion: Histological chorioamnionitis is associated with modest systemic inflammation in maternal and cord blood.
These systemic changes may increase postnatally, potentially undermining their utility in the diagnosis of early-onset
neonatal infection.
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Background
Intrauterine infection and inflammation (IUI) is an important
determinant of spontaneous preterm birth [1], [2]. Infants whose
pregnancies were complicated by IUI have increased risk of
adverse outcomes including perinatal death, early onset neonatal
sepsis, septic shock, pneumonia, intraventricular hemorrhage,
cerebral white matter damage, and long-term disability such as
cerebral palsy [1], [3], [4]. The fetal response to IUI is
characterised by increased levels of proinflammatory cytokines in
the amniotic fluid and cord blood [4], [5], and by inflammation of
the chorionic plate, placental vessels and/or umbilical cord (fetal
vasculitis) [6], [7]. However the relationships between perinatal
PLOS ONE | www.plosone.org 1 December 2012 | Volume 7 | Issue 12 | e51836
inflammation and inflammatory markers in umbilical cord blood,
infant and maternal circulation are incompletely understood.
Intrauterine infection and inflammation is most accurately
diagnosed by histological examination of the placenta. Histological
chorioamnionitis (HCA) is often asymptomatic and clinical signs,
such as fever, uterine tenderness, maternal or fetal tachycardia and
malodorous amniotic fluid, lack both sensitivity and specificity;
over one third of women with these signs do not have histological
evidence of placental inflammation [5], as other causes may
produce similar clinical features [6]. Moreover intrauterine
infection occurs without microbiologically-proven amniotic fluid
infection in over half of cases [7], due to due to fastidious
organisms, sampling limitations and prior exposure to antibiotics.
Molecular techniques for fastidious microorganisms may increase
the diagnostic yield, but are not widely available and their
sensitivity and specificity are unknown. The poor predictive value
of clinical signs and amniotic fluid culture for identifying HCA has
increased interest in readily available inflammatory and haema-
tological markers.
C-reactive protein (CRP), procalcitonin (PCT) and absolute
neutrophil count (ANC) are biomarkers that may be used as
adjunctive tests in the diagnosis of inflammation, sepsis and
infection. CRP is an acute phase reactant produced by the liver in
response to pro-inflammatory cytokines, such as interleukin (IL)-6.
Plasma levels increase 12–24 hours after the onset of inflamma-
tion, when diagnostic clinical signs may be non-specific, and
remains elevated until after stimulus resolves [8]. Along with ANC,
CRP is a well-described marker for bacterial infection in neonates,
children and adults. Elevation of serum CRP in the neonate is due
to endogenous hepatic synthesis, since very low quantities of CRP
cross the placenta [9]. Procalcitonin (PCT) is a peptide prohor-
mone of calcitonin physiologically produced by C-cells in the
thyroid gland. In response to endotoxin and inflammatory
cytokines, PCT it is also synthesised by non-thyroidal tissues,
including monocytes, renal and pancreatic cells, adipose tissue,
and hepatocytes [10].
Procalcitonin (PCT) may have advantages over CRP as
a marker for inflammation or sepsis. PCT concentrations increase
more rapidly than CRP (within 2–4 hours) in response to systemic
inflammation or infection, remain elevated during the inflamma-
tory process and rapidly return to baseline on resolution of the
stimulus [10]. Thus PCT levels more accurately reflect the real-
time extent of inflammation and may be more useful than CRP in
the early diagnosis of infection and monitoring of disease.
However, PCT appears to be of limited clinical utility in the
neonatal setting as it may be elevated in non-infected infants with
other complications such as asyphyxia, respiratory distress and
intracranial haemorrhage [11].
Most data on inflammatory biomarkers in HCA relate to C-
reactive protein (CRP) and routine haematological parameters;
there is less experience with newer markers such as PCT,
especially in the maternal circulation [12]. Few studies that have
specifically investigated the relationship between cord and neo-
natal CRP in neonates exposed to HCA and the results are
inconsistent [13], [14]. A single study of 8 subjects with HCA
showed no difference in cord PCT concentrations in the presence
of HCA [15]. Thus the associations between these markers and
histologically confirmed chorioamnionitis are inconsistent and
their clinical utility remains unclear [16].
The extent to which HCA may confound these diagnostic
markers of neonatal sepsis is unknown, but HCA may affect
inflammatory markers several days postpartum [15]. This is
particularly pertinent in preterm infants, in whom pregnancies are
most likely to be complicated by HCA, whose mothers are likely to
have received intra-partum antibiotics (thereby reducing the yield
of neonatal blood cultures), and who are at the highest risk of early
life sepsis, which is difficult to diagnose clinically [11].
We hypothesised that HCA generates inflammatory changes
that may be detected in the mother at the time of delivery and in
the neonate up to 48 hours following delivery. Our aim was
therefore to investigate the association of HCA and CRP, PCT
and haematological parameters in the mother and baby at the
time of delivery, and in the neonate up to 48 hours following
delivery. We show that HCA has is associated with inflammatory
responses in both the maternal circulation and cord blood and
these may persist in the neonatal circulation postnatally. The
presence of HCA should be considered when interpreting
inflammatory indices in newborn preterm infants.
Methods
Study Population
This was a cross-sectional study of mother-infant pairs recruited
at the only tertiary perinatal center (King Edward Memorial
Hospital) in Western Australia (total population ,2.2 million),
between August 2003 and January 2006. We aimed to recruit
women in preterm labour and those delivering at term in a ratio of
approximately two to one. We enrolled women at deliveries
attended by dedicated study personnel and consequently the study
population was over-represented with multiple pregnancies and
deliveries by caesarean section and under-represented with
spontaneous vaginal deliveries of extreme preterm infants, whose
deliveries frequently occur out-of-hours, when study personnel
were unavailable. We excluded infants with major congenital
abnormalities and mothers whose understanding of English did
not allow fully informed consent. The study was approved by the
King Edward Memorial Hospital for Women institutional ethics
committee. All the subjects who were included in this study
provided informed written consent.
Definitions and Study Procedures
Gestational age was estimated from date of the last menstrual
period, in utero ultrasound before 20 weeks, or in the absence of
antenatal data, the Ballard score at delivery [17]. A section of
umbilical cord, membranes and at least one section including the
chorionic plate were analysed histologically. Histological chor-
ioamnionitis was diagnosed by the presence of inflammatory cells
(predominantly neutrophils) in the chorionic plate and/or
chorioamnionotic membranes according to widely accepted,
reproducible semi-quantitative scoring system [18]. Placental fetal
and maternal responses were graded (grade 0= no inflammation,
1 = early, 2 = intermediate, 3 = advanced) and staged (stage 0=
no inflammation, 1= mild-moderate, 2 = advanced), using these
well-defined criteria [18]. Histological chorioamnionitis was
defined as an abnormal maternal and/or fetal response. An
abnormal fetal response was defined as grade/stage .0, whereas
an abnormal maternal response was defined as grade/stage .1, as
a grade 1 maternal response (indicative of focal or mild maternal
inflammatory response) may not represent an established intra-
amniotic infection.
Demographic and clinical data were collected at delivery.
Maternal data included age, ethnicity, reported smoking, parity,
pregnancy complications, premature rupture of membranes,
length of labour, intrapartum fever, antibiotic exposure, antenatal
steroids, and mode of delivery. Clinical chorioamnionitis was
defined by the presence of at least two of the following features:
intrapartum fever, uterine tenderness, maternal or fetal tachycar-
dia, or malodorous amniotic fluid. Neonatal data included
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gestational age, sex, birth weight, head circumference, length, 1, 5
and 10 minute Apgar scores, ventilatory support, neonatal sepsis
(defined as a single isolate cultured from a sterile site with
suggestive clinical features and a treatment course of antibiotics
[19]), time to discharge, and death.
Sample Collection and Preparation
Immediately prior to delivery, maternal peripheral blood was
collected into lithium-heparin, centrifuged for 10 mins at
3000 rpm and frozen for subsequent PCT and high sensitivity
CRP (hsCRP) measurements. Placental specimens were examined
by an experienced perinatal histopathologist, blinded to clinical
and laboratory data. Tissue samples of HCA cases were cultured
using standard media (chocolate agar and cysteine, lactose and
electrolyte deficient plates) for aerobic bacteria, selective agar for
mycoplasma and ureaplasma, and selective agar and enrichment
broth for listeria.
Umbilical cord blood was collected in ethylene diamine tetra-
acetic acid for full blood count and automated differential and
lithium-heparin gel for plasma assays. Neonatal peripheral blood
samples were collected when sepsis was clinically suspected by one
or more suggestive clinical features: temperature instability,
apnoea, bradycardia, or cardiovascular instability [19]. Neonatal
blood samples were analysed for measurement of full blood count
(0–24 h post-delivery) and CRP (first hour (0–1 h post-delivery),
Day 1 (.1–24 h post-natal age), and Day 2 (24–48 h post-natal
age).
Inflammatory Mediator Assays
High sensitivity (hs)CRP assay was used to measure CRP in the
maternal and cord blood samples as it was hypothesised that the
effect of HCA on CRP would be modest and may not be detected
using he conventional clinical assay, which has a lower limit of
detection of 3–7 mg/L, depending on the assay used. High
sensitivity CRP was measured by latex immunonephelometry
(Dade Behring Nephelometer BN II, Marburg, Germany). The
lower limit of detection was 0.15 mg/L, with values ,0.15 mg/
mL set to zero for statistical analysis. Procalcitonin was measured
by the BRAHMS PCT sensitive immunoluminometric assay on
a Berthold Technologies Lumat LB9507 luminometer (Bad
Wildbad, Germany). The lower limit of detection was 0.01 ug/L
and all samples had a value greater than this. The intra-assay co-
efficient of variation was 4.8% and inter-assay co-efficient of
variation was 5.6%. Cord and neonatal full blood counts were
measured using a Beckman Coulter HmX analyzer (Fullerton,
California, USA).
Postnatal CRP was measured only in neonates where clinically
indicated up to the first 48 hours following delivery. For these
samples, CRP was measured by enzymatic sandwich immunoas-
say using VITROS Chemistry Products CRP Slides (Ortho-
Clinical Diagnostics, Rochester, USA). Until May 2005, the lower
limit of detection for the assay was 7 mg/L. After this time, a more
sensitive slide technique was used (lower limit of detection 3 mg/
L). C-reactive protein values less than the lower limit of detection
were analysed in two ways; with all values below the lower limit of
detection set to 6.5 mg/L and 2.5 mg/L, respectively. The intra-
assay co-efficient of variation was 3.1% and inter-assay co-efficient
of variation was 2.5%. The maximum CRP value was the highest
value for an infant within the first 48 h post-delivery, even if this
was the only available CRP value.
Statistical Analysis
Continuous data were summarised using non-parametric
statistics: medians, interquartile ranges (IQR) and ranges (R),
and Mann-Whitney U tests were used to compare groups.
Categorical data were summarised using frequency distributions.
Pearson’s chi-square tests or Fisher’s exact test were used to
compare frequency distributions between groups.
Linear correlation and linear regression were used to explore
the effect of HCA on maternal, cord and neonatal outcomes.
Given the likely correlation between maternal and neonatal
factors, analysis for maternal and neonatal outcomes used the
number of infants delivered as the overall denominator. Re-
gression models for maternal outcomes were adjusted for co-
existing conditions associated with maternal inflammation; dura-
tion of PROM, intrapartum fever (.38uC), or duration of labour
before delivery. Regression models for neonatal outcomes were
adjusted for factors associated with elevated cytokine levels;
gestational age, ‘small for gestational age’ (according to Australian
normative data) [20], and duration of labour. In addition, cord
and neonatal white cell count and absolute neutrophil count were
adjusted for use of antenatal steroids [21]. Continuous outcomes,
such as PCT and absolute neutrophil count, were log-transformed
to achieve normality. Coefficient of determination (R2) was used to
measure the proportion of variance explained by variables in the
linear regression models. As there was no difference in parameters
for multiple or singleton pregnancies, these were analysed together
(data not shown). For all analyses, P,0.05 was considered
statistically significant. Data was analysed using SPSS statistical
software (version 15.0: Chicago, Illinois).
Results
Study Cohort
A total of 343 mothers, delivering 421 infants, satisfied inclusion
criteria, of whom 247 mothers and their 325 infants had placental
samples; analysis was therefore based on these deliveries. Two
hundred and twenty two (68%) neonates were delivered preterm,
90 (28%) at 28–32 weeks gestational age, and 19 (6%) ,28 weeks
gestational age. The median gestational age was 34 weeks (range
24–42 weeks). Approximately two thirds were delivered by elective
caesarean section (208, 64%), and one third (128, 39%) were
multiple pregnancies.
Placental Histology
Twenty-six placentae (of 247 examined, 10.5%) had HCA with
a maternal response graded more than 1, and/or a fetal response
[18]. The median gestational age of HCA cases was 30 weeks
(IQR 27.5 to 32 weeks) and the majority (23, 88%) of HCA
occurred in single gestation pregnancies. Placental culture results
were available in 17 of 26 HCA cases, of which 11 (of 17, 65%)
were positive. The most common isolates were Mycoplasma hominis
(n = 5), Ureaplasma urealyticum (n = 2), and mixed bacterial species
(n = 4) (Table 1).
Maternal Characteristics
Univariate comparison of mothers with (n = 26) and without
HCA (n= 299) showed that HCA was associated with Aboriginal
or Torres Strait Island descent (6/26 (23%) versus 20/299 (7%);
P= 0.004), and maternal self-reported smoking (10/26 (39%)
versus 42/299 (14%); P= 0.001) (Table 2). Seven (27%) mothers
with HCA had symptoms of clinical chorioamnionitis whereas 4 of
299 (1%) of those without HCA were symptomatic (P,0.001).
Fifteen of 26 (58%) HCA cases had spontaneous vaginal deliveries,
compared to 72/299 (25%) of cases without HCA (P= 0.001).
Antenatal steroids were more prevalent in mothers with HCA (15/
26 (58%) versus 95/299 (32%); P= 0.009.
Inflammatory Markers of Chorioamnionitis
PLOS ONE | www.plosone.org 3 December 2012 | Volume 7 | Issue 12 | e51836
Neonatal Characteristics
Newborns born after HCA-affected pregnancies were more
likely to be preterm (23/26 (89%) versus 199/299 (68%);
P= 0.028) and had a lower gestational age (median 30 (range
23–40) weeks versus 34 (26–42) weeks, respectively, P,0.001).
More HCA cases were born at 28–32 weeks GA (7/26 (27%)
versus 12/299 (4%); P,0.001), and ,28 week GA (11/26 (42%)
versus 79/299 (27%); P,0.001) (Table 3). The only case with
proven early-onset sepsis (EOS) was excluded from analysis as
infection elevates CRP and PCT, potentially confounding the
effects of HCA on inflammatory markers, which was the primary
research question.
Effect of HCA on Maternal hsCRP and Procalcitonin
Maternal hsCRP level was significantly higher in mothers with
HCA (median 26 mg/L (IQR 12.6–61.3, range 2.0–107) versus 5.6
(IQR 2.4–13.6; range 0–108) mg/L; P,0.001), but there was no
difference in median PCT (0.046, R 0.014–0.342 versus 0.037, R
0.011–1.565, P=NS). Multivariable linear regression, adjusting for
duration of prolonged rupture of membranes, length of labour and
intrapartum fever showed a significant association between HCA
and maternal hsCRP (P,0.001), and maternal hsCRP was
significantly higher in mothers with HCA compared to those
without HCA (OR 2.86; 95% CI 1.47–5.57; P= 0.002). There was
no statistically significant relationship between HCA and maternal
PCT.
Effect of HCA on Umbilical Cord hsCRP and Procalcitonin
The median cord PCT level was significantly higher in subjects
with HCA (0.293 (IQR 0.08–0.44, R 0.05–27.37) ug/L versus
0.064 (IQR 0.05–0.10, range 0.01–5.24) ug/L; P,0.001), as was
hsCRP (0, 0–2.9; 0–63.9) mg/L versus (0, 0–0; 0–45.6, P,0.001).


















1 1 0 2 1 1 34 M partial NA
2 1 1 2 2 1 25 S full U. u
3 1 1 1 1 1 33+3 M full neg
4 1 1 2 1 1 32 S partial MCB
5 1 1 1 1 1 40 S partial NA
6 1 1 1 1 1 39 S partial NA
7 2 1 1 1 1 1 25+6 S partial NA
8 2 1 0 0 1 32 S full M. h
9 2 1 1 1 1 1 31 S full neg
10 2 1 1 1 1 1 23 S partial MBF
11 2 1 1 1 1 1 40 S partial NA
12 2 2 2 1 1 1 30+6 S partial neg
13 2 2 0 0 1 27+3 S full M. h
14 2 2 1 1 1 1 29 S partial NA
15 2 2 3 2 1 1 28 M partial NA
16 3 2 1 1 1 1 28+5 S partial M. h
17 3 2 3 2 1 1 27 S partial neg
18 3 2 1 1 1 1 30 S partial NA
19 3 2 3 2 1 1 31 S full MCB
20 3 2 3 2 1 1 30 S full C. a
M. h
21 3 2 3 2 1 1 24+3 S full neg
22 3 2 2 1 1 1 29 S full neg
23 3 2 2 1 1 1 28 S full NA
24 3 2 3 2 1 1 25 S full M. h
U. u
25 3 2 3 2 1 1 31+5 S full MGF
26 3 4 1 1 1 1 35+5 S partial S. a
Total 26 25 24 24 20 24 3M, 23S
Maternal and fetal inflammatory response were staged and graded according to criteria published by Redline et al [18]: *Maternal inflammatory response stage
0 = absent, 1 = early, 2 = intermediate, 3 = advanced chorioamnionitis, grade 1 = mild-moderate, 2 = severe. #Fetal inflammatory response stage 0 = absent, 1 = early,
2 = intermediate, 3 = advanced funisitis, grade 1 = mild-moderate, 2 = severe. HCA was present if maternal response was grade/stage .1 and/or fetal response was
grade/stage .0.
GA=gestational age, Single (S) = single gestation pregnancy, Multiple (M) =multiple gestation pregnancy, Bact. Cult. = bacterial culture result, U. u=Ureaplasma
urealyticum, neg= negative, MCB=mixed coliform bacteria, M. H=Mycoplasma hominis, MBF =mixed bacterial flora, C. A= Candida albicans, MGF=mixed genital flora,
S. a= Staphylococcus aureus, NA =not available.
doi:10.1371/journal.pone.0051836.t001
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For cord PCT, multivariable linear regression showed gestational
age, being small for gestational age, and length of labour
accounted for 30.7% of PCT variation, with HCA contributing
a further 10.5% variance; HCA was a significant variable in the
model (P= 0.001). For cord hsCRP, gestational age, small for
gestational age and length of labour accounted for 3.7% of the
increase in cord hsCRP and HCA contributed a further 9%
variance; HCA was a significant variable in the model (P,0.001).
Effect of HCA on Cord and Neonatal Haematological
Parameters
No significant differences were observed between cord haema-
tological parameters in subjects with and without HCA (Table S1).
Neonatal peripheral blood absolute neutrophil count was similar
in HCA (2.4 (range (1.0–3.3)6109/L) than in those without HCA
(2.0 (range 0.9–4.2)6109/L, P=NS). Gestational age, small for
gestational age, length of labour, and antenatal steroid exposure
affected white blood count and absolute neutrophil count, and the
relationship between HCA and neonatal white blood count and
absolute neutrophil count was further examined using multivari-
able linear regression. For neonatal white cell count, these factors
accounted for 8.6% of variation, with HCA contributing a further
7.1%; HCA was significant in the regression model (P,0.001). For
neonatal absolute neutrophil count, the same variables accounted
Table 2. Demographic and clinical characteristics of maternal
cases with and without histologic chorioamnionitis.
Histologic Chorioamnionitis
Maternal characteristics No Yes P value
n= 299 (92%) n= 26 (8%)
Maternal age* (yrs) 29 29
(26–34) (22–34)
[14–45] [16–43] .779
Maternal ethnic origin .010
Aboriginal/TSI 20 (7%) 6 (23%) .004
Caucasian 241 (82%) 19 (73%)
Other 33 (11%) 1 (4%)
Smoker 42 (14%) 10 (39%) .001
Primigravid 92 (31%) 7 (27%) .393
Antenatal steroids 95 (32%) 15 (58%) .009
PROM{ 100 (34%) 19 (73%) ,.001
Period of PROM (h) {# 0.15 0.50
(0.05–0.24) (0.09–3.45)
[0–13] [0–9] .014
Antibiotics for PROM 31 (11%) 11 (42%) ,.001
Antibiotics prior labour
onset
26 (9%) 11 (42%) ,.001
Antibiotics during labour 50 (17%) 13 (50%) ,.001
Clinical chorioamnionitis 4 (1%) 7 (27%) ,.001
Intrapartum fever .38uC 4 (1%) 6 (23%) ,.001
Mode of delivery .001
Spontaneous VD 72 (25%) 15 (58%)
Assisted VD 19 (7%) 3 (12%)
Emergency CS 3 (1%) –
Elective CS 200 (68%) 8 (31%)
Any labour (1st +2nd stage) 133 (45%) 23 (89%) ,.001




Multiples 125 (43%) 3 (11%) .002
Frequencies expressed as n(%) unless specified.
*Median (Interquartile Range) [Range].
{PROM=Premature rupture of membranes.
#PROM cases only ## Labour cases only.
doi:10.1371/journal.pone.0051836.t002
Table 3. Demographic and clinical characteristics of neonates
with and without histologic chorioamnionitis.
Histologic Chorioamnionitis
Neonatal characteristics No Yes P value
n= 299 (92%) n = 26 (8%)
Gestational age * 34 30
(31–38) (27–32)
[26–42] [23–40] ,.001
,28w 12 (4%) 7 (27%) ,.001
28–32w 79 (27%) 11 (42%)
32–37w 108 (37%) 5 (19%)
37+w 95 (32%) 3 (12%)
Preterm 199 (68%) 23 (89%) .028
Male gender 132 (45%) 10 (62%) .527
Birth weight* 2158 1575
(1510–3081) (1048–2151)
[495–4945] [585–3565] .002
Expected birthweight* 2282 1403
(1581–3187) (999–1432)
[865–3739] [591–3463] ,.001
Head circumference* 31 29
(28–34) (25–30)
[21–39] [21–37] .001
Length * 45 40
(40–49) (36–45)
[30–59] [30–51] .001
SGA (,10%ile){ 41 (14%) 2 (8%) .551
Apgar Scores
Apgar 1 minute ,6 53 (18%) 12 (46%) .001
Apgar 5 minute ,6 10 (3%) 3 (12%) .029
Any ventilation 133 (45%) 19 (73%) .005
Neonatal sepsis
(early & late onset)
17 (6%) 5 (19%) .009
Neonatal early onset
sepsis (,72 h)
1 (,1%) - .768
Time to discharge (d)* 19 32
(5–39) (14–62)
[0–123] [0–97] .014
Neonatal death 1 (,1%) 2 (8%) ,.001
Frequencies expressed as n(%) unless specified *Median (Interquartile Range)
[Range].
{SGA= Small for gestational age (,10th percentile).
doi:10.1371/journal.pone.0051836.t003
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for 23.8% of variation; HCA contributed a further 3.4% and
remained significant (P= 0.002).
Histological Chorioamnionitis and Neonatal CRP
C-reactive protein was measured in the peripheral blood of 217
neonates (Table S2). Twenty-three of 26 (89%) of neonates
exposed to HCA and 191/299 (64%) of unexposed neonates had
CRP measured within the first 48 h of life. Given the proportion of
missing data for CRP, particularly in the non-HCA group,
regression analysis was only performed for maximal CRP for each
infant recorded within the first 48 h after delivery.
Figure 1 shows neonatal CRP results during the first 48 h of life.
Linear regression for the effect of HCA on neonatal maximal CRP
in the first 48 h showed gestational age, small for gestational age
and length of labour accounted for only 1.0% of variation in
postnatal CRP. The addition of HCA accounted for a further
9.0%; the contribution of HCA to CRP was significant (P,0.001).
Analysis of the timing of maximal postnatal CRP in neonates
exposed to HCA showed a significant relationship between HCA
and maximal CRP at Day 1 (P,0.001) and Day 2 (P= 0.03), but
no significant relationship with maximal CRP levels at birth.
Discussion
These findings highlight the possible relationship between HCA
and inflammatory and haematological markers in the maternal,
cord and neonatal circulation. In the majority of mothers, HCA
was asymptomatic and associated with a modest increase in
hsCRP, but not in PCT levels. In umbilical cord blood, HCA was
associated with increased PCT and hsCRP, but did not affect cord
white cell count or absolute neutrophil count. However, there was
a significant increase in inflammatory and haematological markers
in infants exposed to HCA without early onset sepsis, peaking at
24 h of age. Histological choriomanionitis may therefore result in
sustained inflammatory changes in the neonatal circulation, in the
absence of microbiologically diagnosed infection.
The observation of higher CRP but no difference in PCT in the
mothers with HCA is in keeping with many previous studies,
although data are not uniformly consistent and most studies are on
pregnancies complicated by prolonged rupture of membranes
[22], [23]. The methodology of studies investigating maternal
CRP in diagnosing HCA varies, particularly in relation to the
CRP cut-off values [16], and there are few data on hsCRP [22].
Although there appears to be significant differences in maternal
CRP levels in those with and without HCA, the considerable
overlap between these groups may limit the clinical utility of CRP
in diagnosing HCA [23]. In infants exposed to HCA we found
significant differences in PCT, and to a lesser extent, hsCRP
concentrations cord blood. The discrepant CRP and PCT findings
between mothers and infants may reflect differential regulation of
CRP and PCT production by placental cytokines [24], [25]. In
addition the kinetics of CRP and PCT differ; PCT is synthesised
more quickly and CRP degrades more slowly [26]. Serial CRP
and PCT measurements postnatally in infants exposed to HCA
may be informative.
Perinatal inflammation is associated with increased umbilical
cord inflammatory cytokines including interleukin (IL)-6 and acute
phase reactants such as CRP [26], [27], [28], but the impact on
inflammatory markers in the early neonatal period is less well-
described. Placental inflammation in extremely preterm newborns
is associated with elevation in concentrations of acute phase
reactants during the first three days after birth [29]. Our data
suggest that even in infants without obvious evidence of bacterial
infection, the response to perinatal inflammation persists post-
natally and may be sufficient to cause clinically significant changes
Figure 1. C-reactive protein (CRP) concentrations in newborns with and without histologic chorioamnionitis (HCA) in the first hour
(Day 0), 1–24 hours (Day 1) and 24–48 hours (Day 2) following delivery.
doi:10.1371/journal.pone.0051836.g001
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in acute phase reactants. The peak CRP occurred on day 1,
reflecting the kinetics of CRP production - detectable within 6 h
and peaking at approximately 48 h [30].
Procalcitonin, like CRP, is regulated by cytokines that increase
early in HCA [31]. In adult intensive care, PCT may have
advantages over CRP in differentiating bacterial infection from
other causes of inflammation [32]. Here we report that cord PCT
concentrations were significantly higher in neonates exposed to
HCA. Although our study aimed to investigate the more common
influences on PCT and neonatal PCT is not routinely measured,
our data suggest that gestational age, small for gestational age and
length of labour and HCA account for almost half of the variation
in cord PCT levels, which therefore may limit its utility in the
diagnosis of early neonatal infection. There are few data on PCT
and HCA. One study reported that HCA did not influence cord
PCT levels, but was associated with a post-natal increase in PCT
at 72 h and 7 days [15]. Although higher PCT levels are reported
in infants who subsequently develop sepsis [26], these studies did
not examine placental histology.
Histological chorioamnionitis was associated with increased
absolute neutrophil in the first 48 h of life, consistent with other
data [33]. There was marked overlap in WCC and ANC between
HCA and non-HCA groups, limiting their clinical utility in
identifying HCA and in diagnosing EOS in HCA-exposed infants.
The strengths of our study include quantification of HCA by an
experienced perinatal histopathologist, blinded to outcomes and
analysis of parameters commonly used in clinical practice in
maternal, fetal and post-natal samples. We acknowledge some
limitations, most importantly the non-representative nature of our
sample, which reflected the resources available to recruit mothers
and infants and to process samples. We therefore enrolled a relative
over-representation of moderately preterm infants and of those
born by caesarean section. Therefore, and despite the overall
sample size, there were fewer cases of HCA than we have
previously observed in a more preterm cohort drawn from the
same population [34], and thus there was some reduced power
and limitation in the number of variables used in regression
modelling. The lower frequency of HCA was likely due in part to
the over-representation of elective caesarean sections and elective
deliveries for multiple pregnancies, and under-representation of
spontaneous vaginal deliveries and extremely preterm infants. As
HCA predominantly occurred as expected in spontaneous pre-
term, singleton vaginal deliveries, the findings reflect the overall
maternal and neonatal response to HCA, but inclusion of
extremely preterm infants would be additionally informative, as
this group has a higher incidence of HCA and of neonatal
infection. Further studies in a larger unselected preterm popula-
tion are therefore necessary to confirm our findings. Placental
samples were not available from all deliveries, although this is less
likely to introduce a systematic bias, as placental histology is part of
routine clinical practice in all deliveries less than 34 weeks
gestational age and from all placentae successfully collected as part
of the study, irrespective of gestational age or clinical features. The
higher prevalence of antenatal steroids in the mothers with HCA
may have diminished the extent of inflammation, thus dampening
the effect of HCA on inflammatory biomarkers. Despite this, our
study did find higher CRP concentrations in newborns exposed to
HCA. Maternal blood contamination of cord blood samples is also
unlikely to have been a major limitation; our sampling protocols
aim to reduce maternal blood contamination of cord blood, which
largely reflects the fetal circulation at late gestation [35]. As
postnatal CRP was only measured on infants who were clinically
suspected of having sepsis, a significant proportion of neonates did
not have CRP measured postnatally, precluding regression
analysis of post-natal CRP data. It would be of interest for future
studies to investigate inflammatory markers in all infants exposed
to HCA, irrespective of whether infection was clinically suspected.
Conclusions
Histological chorioamnionitis has differential effects on mater-
nal and cord/neonatal inflammatory markers. In the newborn
exposed to HCA, CRP, white cell count and absolute neutrophil
count are increased when compared to newborns without HCA.
This may confound the interpretation of these common diagnostic
markers of early neonatal sepsis. Further investigations in larger
unselected populations of preterm infants, with serial measure-
ment for a longer period of hsCRP and PCT, irrespective of
suspected sepsis, would be informative about the effects of HCA
on postnatal inflammatory markers and would refine the use of
plasma and haematological markers in the diagnosis of neonatal
infection.
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